Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study. (Q51390729)

4 April 2018

title

Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study. (English)

1 reference

4 April 2018

0 references

1 reference

Lei Kong

1

1 reference

4 April 2018

Junjie Zhu

2

1 reference

4 April 2018

Wenxia Han

3

1 reference

4 April 2018

Xiuyun Jiang

4

1 reference

4 April 2018

Min Xu

5

1 reference

4 April 2018

Yue Zhao

6

1 reference

4 April 2018

Qiongzhu Dong

7

1 reference

4 April 2018

Zengfen Pang

8

1 reference

4 April 2018

Qingbo Guan

9

1 reference

4 April 2018

Ling Gao

10

1 reference

4 April 2018

Jiajun Zhao

11

1 reference

4 April 2018

Lei Zhao

12

1 reference

4 April 2018

publication date

21 September 2010

1 reference

4 April 2018

published in

Acta Diabetologica

1 reference

4 April 2018

volume

48

1 reference

4 April 2018

issue

1

1 reference

4 April 2018

page(s)

61-69

1 reference

4 April 2018

https://scigraph.springernature.com/pub.10.1007/s00592-010-0226-0

exact match

0 references

cites work

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0226-0

Islet beta cell failure in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0226-0

Genome-wide association studies in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0226-0

Novel insights into the etiology of diabetes from genome-wide association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0226-0

A genome-wide association study identifies novel risk loci for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0226-0

Genome-wide association studies provide new insights into type 2 diabetes aetiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0226-0

A new era for Type 2 diabetes genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0226-0

Assessing the combined impact of 18 common genetic variants of modest effect sizes on type 2 diabetes risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0226-0

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0226-0

Serum microRNAs are promising novel biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0226-0

Circulating microRNAs as stable blood-based markers for cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0226-0

Serum-based microRNAs: are we blinded by potential?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0226-0

Role of microRNAs in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0226-0

Molecular medicine of microRNAs: structure, function and implications for diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0226-0

MicroRNAs in diabetes: tiny players in big disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0226-0

Identification of glucose-regulated miRNAs from pancreatic {beta} cells reveals a role for miR-30d in insulin transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0226-0

MicroRNA-124a regulates Foxa2 expression and intracellular signaling in pancreatic beta-cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0226-0

MicroRNA-9 controls the expression of Granuphilin/Slp4 and the secretory response of insulin-producing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0226-0

A pancreatic islet-specific microRNA regulates insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0226-0

Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0226-0

Alterations in microRNA expression contribute to fatty acid-induced pancreatic beta-cell dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0226-0

miR-375 maintains normal pancreatic alpha- and beta-cell mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0226-0

Phylogenetic shadowing and computational identification of human microRNA genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0226-0

Identification of hundreds of conserved and nonconserved human microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0226-0

Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0226-0

Common variants in CDKAL1, CDKN2A/B, IGF2BP2, SLC30A8, and HHEX/IDE genes are associated with type 2 diabetes and impaired fasting glucose in a Chinese Han population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0226-0

Association between insulin secretion, insulin sensitivity and type 2 diabetes susceptibility variants identified in genome-wide association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0226-0

Foxa2 regulates multiple pathways of insulin secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0226-0

Effects of changing diagnostic criteria on the risk of developing diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0226-0

The natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore Longitudinal Study of Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0226-0

Normal fasting plasma glucose levels and type 2 diabetes in young men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0226-0

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0226-0

Implications of the diabetes prevention program and Look AHEAD clinical trials for lifestyle interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-010-0226-0

10.1007/S00592-010-0226-0

21 January 2018

Identifiers

DOI

1 reference

4 April 2018

PubMed ID

20857148

1 reference

4 April 2018